AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopple, J. D.
Right arrow Articles by Ament, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopple, J. D.
Right arrow Articles by Ament, M. E.
Agricola
Right arrow Articles by Kopple, J. D.
Right arrow Articles by Ament, M. E.

American Journal of Clinical Nutrition, Vol 52, 846-853, Copyright © 1990 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Effect of intravenous taurine supplementation on plasma, blood cell, and urine taurine concentrations in adults undergoing long-term parenteral nutrition

JD Kopple, NE Vinton, SA Laidlaw and ME Ament
Department of Medicine, School of Medicine, UCLA, Torrance 90509.

Thirty-four adults undergoing long-term parenteral nutrition (TPN) were treated either with or without intravenous taurine for less than or equal to 24 mo. Statistical comparisons were carried out in eight patients randomly assigned to receive intravenous taurine, usually 10 mg.kg-1.d-1, and 10 patients not receiving taurine. Compared with normal adults, baseline plasma taurine and urine taurine-creatinine ratios were decreased in both groups and platelet taurine was reduced in the taurine-treated group. During taurine treatment the mean of the mean values for taurine became normal in plasma and platelets and remained normal in erythrocytes, granulocytes, and lymphocytes; urine taurine-creatinine ratios rose to approximately five times normal. During follow-up, patients not given taurine had plasma, erythrocyte, and granulocyte taurine and urine taurine-creatinine ratios below normal values and the concentrations of taurine-treated patients. Their platelet taurine was also subnormal. Thus, 10 mg taurine.kg-1.d-1 intravenously normalizes plasma and blood cell taurine concentrations in long-term TPN patients.


This article has been cited by other articles:


Home page
 J. Nutr.Home page
P. Furst and P. Stehle
What Are the Essential Elements Needed for the Determination of Amino Acid Requirements in Humans?
J. Nutr., June 1, 2004; 134(6): 1558S - 1565S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. Chiarla, I. Giovannini, J. H. Siegel, G. Boldrini, and M. Castagneto
The Relationship between Plasma Taurine and Other Amino Acid Levels in Human Sepsis
J. Nutr., September 1, 2000; 130(9): 2222 - 2227.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
P. Fürst
Old and New Substrates in Clinical Nutrition
J. Nutr., May 1, 1998; 128(5): 789 - 796.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The American Society for Nutrition